Literature DB >> 20473602

Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.

Courtney Doughty Rice1, Jennifer Gamm Ruschman, Lisa J Martin, Jennifer B Manders, Erin Miller.   

Abstract

Telephone disclosure of BRCA1/2 molecular genetic test results has been proposed as a feasible alternative to traditional in-person results disclosure. The purpose of this study was to investigate the relationship between method of result disclosure with the patient outcome variables of knowledge, cancer worry, cancer risk perception, satisfaction, and cancer screening and prophylactic surgery behaviors. Study participants included 228 women who completed retrospective, self-administered, mailed surveys regarding their pre-test genetic counseling and results disclosure. No significant relationships were found between result disclosure method and the outcome variables investigated. A majority (90%) of individuals who received positive results by telephone returned for follow up visits. Factors which genetic counselors believed influenced their clinical decision to offer telephone disclosure, such as history of breast cancer, a priori risk of genetic mutation and family history of known mutation were not shown to significantly impact the actual disclosure method. This study suggests that telephone results disclosure is clinically appropriate when counselors utilize their clinical judgment to determine which patients are appropriate candidates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473602     DOI: 10.1007/s10689-009-9303-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  32 in total

1.  Recommendations for Telephone Counseling.

Authors:  K E Ormond; J Haun; L Cook; D Duquette; C Ludowese; A L Matthews
Journal:  J Genet Couns       Date:  2000-02       Impact factor: 2.537

2.  Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.

Authors:  Erna Claes; Gerry Evers-Kiebooms; Andrea Boogaerts; Marleen Decruyenaere; Lieve Denayer; Eric Legius
Journal:  Am J Med Genet A       Date:  2003-01-01       Impact factor: 2.802

3.  Assessment of the Effectiveness of Genetic Counseling by Telephone Compared to a Clinic Visit.

Authors:  Karan K Sangha; Anita Dircks; Sylvie Langlois
Journal:  J Genet Couns       Date:  2003-04       Impact factor: 2.537

4.  BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening.

Authors:  Aideen McInerney-Leo; Donald Hadley; Ronald G Kase; Therese R Giambarresi; Jeffery P Struewing; Barbara Bowles Biesecker
Journal:  Am J Med Genet A       Date:  2006-10-15       Impact factor: 2.802

Review 5.  Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.

Authors:  Angela Trepanier; Mary Ahrens; Wendy McKinnon; June Peters; Jill Stopfer; Sherry Campbell Grumet; Susan Manley; Julie O Culver; Ronald Acton; Joy Larsen-Haidle; Lori Ann Correia; Robin Bennett; Barbara Pettersen; Terri Diamond Ferlita; Josephine Wagner Costalas; Katherine Hunt; Susan Donlon; Cecile Skrzynia; Carolyn Farrell; Faith Callif-Daley; Catherine Walsh Vockley
Journal:  J Genet Couns       Date:  2004-04       Impact factor: 2.537

6.  Visualism in community nursing: implications for telephone work with service users.

Authors:  K Wilson; A Williams
Journal:  Qual Health Res       Date:  2000-07

7.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

8.  Women's perceptions of the effectiveness of telephone support and education on their adjustment to breast cancer.

Authors:  Margaret Chamberlain Wilmoth; Lorraine Tulman; Elizabeth Ann Coleman; Carol Beth Stewart; Nelda Samarel
Journal:  Oncol Nurs Forum       Date:  2006-01-01       Impact factor: 2.172

Review 9.  Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.

Authors:  Henry T Lynch; Edibaldo Silva; Carrie Snyder; Jane F Lynch
Journal:  Breast J       Date:  2007-12-11       Impact factor: 2.431

Review 10.  Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.

Authors:  Janice L Berliner; Angela Musial Fay
Journal:  J Genet Couns       Date:  2007-05-17       Impact factor: 2.717

View more
  13 in total

1.  Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.

Authors:  Rosie O'Shea; Marie Meany; Cliona Carroll; Nuala Cody; David Healy; Andrew Green; Sally Ann Lynch
Journal:  J Genet Couns       Date:  2015-09-26       Impact factor: 2.537

2.  Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.

Authors:  Anita Y Kinney; Laurie E Steffen; Barbara H Brumbach; Wendy Kohlmann; Ruofei Du; Ji-Hyun Lee; Amanda Gammon; Karin Butler; Saundra S Buys; Antoinette M Stroup; Rebecca A Campo; Kristina G Flores; Jeanne S Mandelblatt; Marc D Schwartz
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

3.  Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.

Authors:  Marc D Schwartz; Heiddis B Valdimarsdottir; Beth N Peshkin; Jeanne Mandelblatt; Rachel Nusbaum; An-Tsun Huang; Yaojen Chang; Kristi Graves; Claudine Isaacs; Marie Wood; Wendy McKinnon; Judy Garber; Shelley McCormick; Anita Y Kinney; George Luta; Sarah Kelleher; Kara-Grace Leventhal; Patti Vegella; Angie Tong; Lesley King
Journal:  J Clin Oncol       Date:  2014-01-21       Impact factor: 44.544

4.  Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.

Authors:  Linda Patrick-Miller; Brian L Egleston; Mary Daly; Evelyn Stevens; Dominique Fetzer; Andrea Forman; Lisa Bealin; Christina Rybak; Candace Peterson; Melanie Corbman; Angela R Bradbury
Journal:  Patient Educ Couns       Date:  2013-08-19

5.  Genetic counseling content: How does it impact health behavior?

Authors:  Kimberly M Kelly; Lee Ellington; Nancy Schoenberg; Thomas Jackson; Stephanie Dickinson; Kyle Porter; Howard Leventhal; Michael Andrykowski
Journal:  J Behav Med       Date:  2014-12-23

6.  Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force.

Authors:  Stephanie A Cohen; Monica L Marvin; Bronson D Riley; Hetal S Vig; Julie A Rousseau; Shanna L Gustafson
Journal:  J Genet Couns       Date:  2013-04-25       Impact factor: 2.537

7.  Report from the National Society of Genetic Counselors service delivery model task force: a proposal to define models, components, and modes of referral.

Authors:  Stephanie A Cohen; Shanna L Gustafson; Monica L Marvin; Bronson D Riley; Wendy R Uhlmann; S Bonnie Liebers; Julie A Rousseau
Journal:  J Genet Couns       Date:  2012-05-08       Impact factor: 2.537

8.  Analysis of Advantages, Limitations, and Barriers of Genetic Counseling Service Delivery Models.

Authors:  Stephanie A Cohen; Rachelle C Huziak; Shanna Gustafson; Robin E Grubs
Journal:  J Genet Couns       Date:  2016-01-14       Impact factor: 2.537

9.  Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition.

Authors:  Linda J Patrick-Miller; Brian L Egleston; Dominique Fetzer; Andrea Forman; Lisa Bealin; Christina Rybak; Candace Peterson; Melanie Corbman; Julio Albarracin; Evelyn Stevens; Mary B Daly; Angela R Bradbury
Journal:  JMIR Res Protoc       Date:  2014-10-29

Review 10.  Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review.

Authors:  Adam Hudson Buchanan; Alanna Kulchak Rahm; Janet L Williams
Journal:  Front Oncol       Date:  2016-05-13       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.